KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Equity Ratio (2017 - 2025)

Historic Equity Ratio for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 0.03.

  • Amneal Pharmaceuticals' Equity Ratio fell 1298.06% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year decrease of 1298.06%. This contributed to the annual value of 0.03 for FY2024, which is 64274.58% down from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Equity Ratio stood at 0.03 for Q3 2025, which was down 1298.06% from 0.03 recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Equity Ratio ranged from a high of 0.1 in Q1 2022 and a low of 0.04 during Q1 2025
  • Moreover, its 5-year median value for Equity Ratio was 0.04 (2023), whereas its average is 0.03.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 1312.97% in 2022, then crashed by 64274.58% in 2024.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Equity Ratio stood at 0.09 in 2021, then plummeted by 48.01% to 0.05 in 2022, then tumbled by 88.1% to 0.01 in 2023, then tumbled by 642.75% to 0.03 in 2024, then grew by 2.34% to 0.03 in 2025.
  • Its last three reported values are 0.03 in Q3 2025, 0.03 for Q2 2025, and 0.04 during Q1 2025.